| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |